Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2015

Aug 25, 2015

34595_dirs_2015-08-25_aba72cdb-66a2-4e92-8b1a-080733395330.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2015-08-21

Reporting Person: Dougherty Connie Leigh (VP, Business Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-08-21 Common Stock P 6900 $1.42 Acquired 6900 Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.40 to $1.44, inclusive. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.